These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26288999)

  • 1. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016; 42(4):676-84. PubMed ID: 26288999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016 Apr; 42(4):676-684. PubMed ID: 26266963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
    Patel KT; Chotal NP
    Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polysorbate 80 quality on photostability of a monoclonal antibody.
    Singh SR; Zhang J; O'Dell C; Hsieh MC; Goldstein J; Liu J; Srivastava A
    AAPS PharmSciTech; 2012 Jun; 13(2):422-30. PubMed ID: 22362139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing the microbiological quality of pharmaceutical excipients.
    Cundell AM
    PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on building index system of risk assessment of post-marketing Chinese patent medicine based on AHP-fuzzy neural network].
    Li Y; Xie Y; Fu Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2828-30. PubMed ID: 22292377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances.
    Humfrey CD
    Toxicol Sci; 2007 Nov; 100(1):24-8. PubMed ID: 17656486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk grade assessment of sudden water pollution based on analytic hierarchy process and fuzzy comprehensive evaluation.
    Zhang H; Li W; Miao P; Sun B; Kong F
    Environ Sci Pollut Res Int; 2020 Jan; 27(1):469-481. PubMed ID: 31797271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high resolution mass spectrometry for analysis of polymeric excipients in drug delivery formulations.
    Perez Hurtado P; Lam PY; Kilgour D; Bristow A; McBride E; O'Connor PB
    Anal Chem; 2012 Oct; 84(20):8579-86. PubMed ID: 23003319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods.
    Braun AC; Ilko D; Merget B; Gieseler H; Germershaus O; Holzgrabe U; Meinel L
    Eur J Pharm Biopharm; 2015 Aug; 94():559-68. PubMed ID: 25513959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on selecting the suitable solubilizing excipients for Shengmai injection].
    Zhang SF; Yan D; Tang HY; Li HB; Wang YS; Xiao XH; Yang M
    Zhong Yao Cai; 2009 Jun; 32(6):969-72. PubMed ID: 19764337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid Pythagorean fuzzy AHP - CoCoSo framework to rank the performance outcomes of circular supply chain due to adoption of its enablers.
    Lahane S; Kant R
    Waste Manag; 2021 Jul; 130():48-60. PubMed ID: 34049267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated MCDM Model for Conveyor Equipment Evaluation and Selection in an FMC Based on a Fuzzy AHP and Fuzzy ARAS in the Presence of Vagueness.
    Nguyen HT; Dawal SZ; Nukman Y; Rifai AP; Aoyama H
    PLoS One; 2016; 11(4):e0153222. PubMed ID: 27070543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for the Use of Polysorbates in Biopharmaceuticals.
    Jones MT; Mahler HC; Yadav S; Bindra D; Corvari V; Fesinmeyer RM; Gupta K; Harmon AM; Hinds KD; Koulov A; Liu W; Maloney K; Wang J; Yeh PY; Singh SK
    Pharm Res; 2018 May; 35(8):148. PubMed ID: 29797101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined.
    Hertrampf A; Müller H; Menezes JC; Herdling T
    Int J Pharm; 2015 Nov; 495(1):447-458. PubMed ID: 26342249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods.
    Jaberidoost M; Olfat L; Hosseini A; Kebriaeezadeh A; Abdollahi M; Alaeddini M; Dinarvand R
    J Pharm Policy Pract; 2015; 8(1):9. PubMed ID: 25838919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Excipient Interactions Evaluated via Nuclear Magnetic Resonance Studies in Polysorbate-Based Multidose Protein Formulations: Influence on Antimicrobial Efficacy and Potential Study Approach.
    Torosantucci R; Furtmann B; Elshorst B; Pfeiffer-Marek S; Hartleb T; Andres N; Bussemer T
    J Pharm Sci; 2018 Oct; 107(10):2531-2537. PubMed ID: 29883667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of risk factors in forest road design and construction activities with fuzzy analytic hierarchy process approach in Turkey.
    Akay AO; Demir M; Akgul M
    Environ Monit Assess; 2018 Aug; 190(9):561. PubMed ID: 30167894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.